Launch

D-Cubed Series: Article 2 – The Competitive Divide of Real-World Data in Healthcare

Accelerating Therapy Uptake with Behavior‑Led HCP Segmentation

Diaceutics x DeepIntent: Physician Segmentation That Brings Real-Time Diagnostic Insight to HCP Engagement

Join us at CAP26

Our team will be in Las Vegas from 3-6 October for CAP26.

Precision for All: Watch the New Diaceutics Manifesto

Diaceutics empowers biopharma to enhance patient outcomes by providing data-driven solutions for diagnostic-driven therapies. Ensuring every eligible patient receives timely and  effective treatment.

Building the Pathway for a First-In-Class Oncology Launch

Discover how Diaceutics built a successful commercialization pathway for a first-in-class oncology therapy, enabling timely patient identification and physician engagement in a rare biomarker population.

Reigniting Momentum: A Curated Round‑Up of This Season’s Most Impactful Insights

Discover how real-time diagnostic insights and expert-led engagement can rebuild prescriber confidence and reignite brand momentum.

Seamless Diagnostic Testing: 12 Recommendations to Drive Your Launch Strategy to Success

Explore key barriers to seamless diagnostic testing in precision medicine and discover strategies to enhance patient identification and treatment outcomes.

The Precision Medicine Webinar Series: Accelerate Precision Medicine

Watch the last webinar in our Precision Medicine Series from 12th December, 2024, to explore strategies for improving biomarker adoption and optimizing therapeutic outcomes in the evolving healthcare landscape.

The Precision Medicine Webinar Series: Cutting through the noise in clinical education

Watch our third Precision Medicine Webinar with Gosia Leitch to explore data-driven strategies that enhance physician engagement and boost biomarker testing rates for successful therapy adoption.

The Precision Medicine Webinar Series: Harnessing Real-World Data

Watch our second webinar in precision medicine series to explore data-driven strategies for therapy adoption, provider engagement, and improving patient outcomes in the evolving healthcare landscape.

Speed to Market Starts Before the Prescription

Discover how Diaceutics and DeepIntent revolutionize pharma marketing by shifting focus to real-time diagnostic intelligence, enhancing engagement before prescriptions are written.

From Test to Treatment: Closing the Final Mile in Patient Care

Discover how real-time support bridges gaps in patient care, enhancing treatment pathways and outcomes through targeted commercialization and expert engagement in precision medicine.

Diaceutics x DeepIntent Partnership: Transforming HCP Engagement with Real-Time Diagnostic Solutions and Genomic Audiences

Discover how Diaceutics and DeepIntent enhance HCP engagement with real-time diagnostic solutions, empowering life sciences marketers to optimize campaigns based on dynamic patient data.

AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

Why Commercial Strategy Must Step Up to Unlock Biomarker Testing and Actionability

Unlock the future of oncology with insights on biomarker testing, ADCs, ctDNA, and digital pathology trends shaping your commercial strategy. Stay competitive in precision medicine.

Driving Global Diagnostic Accuracy for Biomarker Quantification in a Female-Specific Cancer

Discover how Diaceutics enhanced biomarker quantification accuracy for a new cancer therapy, improving diagnosis and patient identification through global studies and targeted training for pathologists.

Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision

Engage healthcare professionals effectively with data-driven strategies that enhance treatment decisions and improve patient outcomes in this informative online webinar.

Delivering precision medicine success through a multi-year commercialization partnership

Discover how a global pharmaceutical leader successfully launched a first-in-class oncology therapy through strategic partnerships, accelerating testing readiness and driving adoption in precision medicine.

Reignite Momentum with Precision: Real-Time Targeting and Engagement

Join industry leaders Gosia Leitch and Kelly Williams on February 12, 2025, to explore real-time targeting and engagement strategies in pharmaceutical diagnostics.

From Insight to Impact: Accelerating precision medicine adoption with the 6A™ Strategic Framework

Discover how the 6A™ Strategic Framework accelerates precision medicine adoption, revealing insights and strategies for successful commercialization and improved patient outcomes. Join our webinar for expert guidance.

D-Cubed Full report 2025

Explore D-Cubed Pharma's comprehensive report on how Diagnostics, Data, and Digital transform pharma launch performance and patient access in 2026 and beyond.

Precision Over Presence: Why Personalization At Scale Drives Better Patient Engagement

Discover how Diaceutics empowers pharma marketers with data-driven solutions for effective HCP targeting and improved commercial outcomes.

ESMO 2025: Top 5 Key Cancer Diagnostics Takeaways From Our Experts

Discover 5 key insights from ESMO 2025 on cancer diagnostics, focusing on ctDNA, antibody-drug conjugates, and innovative strategies for improving patient outcomes in precision medicine.

Navigating Precision Commercialization

Explore innovative strategies for precision commercialization in biopharma. Learn how to enhance launch models and accelerate market adoption of targeted therapies.

Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

Strategies for Launch Success

Watch our Precision Medicine Webinar to explore strategies for successful therapy adoption and commercialization in the evolving precision medicine landscape.

Precision Oncology Paradigm Report

Explore how a companion diagnostic approach to precision oncology can reduce R&D costs and improve patient outcomes by efficiently targeting treatments to eligible patients.

D-Cubed Pharma ROI: The $20B Advantage

Discover how the D-Cubed Model transforms pharma ROI through diagnostics, data, and digital strategies, leading to faster drug launches and enhanced patient access.

Transforming Physician Identification: Leverage Real-Time Data to Reach Every Eligible Patient

Transform your physician engagement strategies with real-time data insights to ensure every eligible patient receives optimal therapy. Join our expert-led discussion online.

Redefining HCP Engagement with Clinical, Behavioral & Companion Diagnostics

Transform HCP engagement by integrating clinical, behavioral, and companion diagnostics data for precise targeting and improved outreach effectiveness. Discover the future of pharma marketing.

Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks

Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.

Precision Medicine Execution: Accelerating Diagnostic Impact

Join our webinar to explore the 6A™ Strategic Framework for accelerating diagnostic impact in precision medicine through actionable insights and expert guidance.

Complexity to Clarity: Using Multi-Modal Data to drive commercial success

Watch our webinar to explore how a multi-modal data approach can simplify complexities in precision medicine and enhance commercialization strategies for better patient outcomes.

Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape

Explore strategies for biotech commercialization amid evolving investment landscapes, focusing on precision and rare disease therapies. Join industry experts in navigating funding challenges and enhancing patient outcomes.

ASCO 2025 Highlights: Critical Advancements in Precision Oncology

Addressing the Economic and
Operational Issues of the
Clinical Practice Gaps in NSCLC

This paper presents five key recommendations to tackle economic and operational barriers hindering access to precision medicine for NSCLC patients.

Current and anticipated future use of MRD in hematological and solid tumors​

This report explores the current and future use of minimal residual disease (MRD) testing, uncovering adoption trends, clinical applications, and commercial implications.

How Timely Expert-Led Education Accelerates Clinical Decision-Making

Physicians make treatment decisions in a narrow window. Learn why timely, peer-to-peer education closes the gap that digital content alone can't reach.